HRP940825A2 - Process for the preparation of basically susbtituted 5-halothienoisothiazol-3(2h)-one-1,1-dioxides - Google Patents

Process for the preparation of basically susbtituted 5-halothienoisothiazol-3(2h)-one-1,1-dioxides

Info

Publication number
HRP940825A2
HRP940825A2 HR940825A HRP940825A HRP940825A2 HR P940825 A2 HRP940825 A2 HR P940825A2 HR 940825 A HR940825 A HR 940825A HR P940825 A HRP940825 A HR P940825A HR P940825 A2 HRP940825 A2 HR P940825A2
Authority
HR
Croatia
Prior art keywords
dioxides
preparation
halothienoisothiazol
susbtituted
basically
Prior art date
Application number
HR940825A
Other languages
English (en)
Inventor
Dieter Binder
Franz Rovenszky
Original Assignee
Chem Pharm Forsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chem Pharm Forsch Gmbh filed Critical Chem Pharm Forsch Gmbh
Publication of HRP940825A2 publication Critical patent/HRP940825A2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR940825A 1988-02-18 1994-10-26 Process for the preparation of basically susbtituted 5-halothienoisothiazol-3(2h)-one-1,1-dioxides HRP940825A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT88390A ATA39088A (de) 1988-02-18 1988-02-18 Basisch substituierte thienoisothiazol-3(2h)-on-1,1-dioxide und ihre pharmazeutisch vertraeglichen salze, verfahren zu ihrer herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
HRP940825A2 true HRP940825A2 (en) 1996-04-30

Family

ID=3489327

Family Applications (1)

Application Number Title Priority Date Filing Date
HR940825A HRP940825A2 (en) 1988-02-18 1994-10-26 Process for the preparation of basically susbtituted 5-halothienoisothiazol-3(2h)-one-1,1-dioxides

Country Status (28)

Country Link
US (1) US4929616A (no)
EP (1) EP0328913B1 (no)
JP (1) JPH01249779A (no)
KR (1) KR890013033A (no)
CN (1) CN1024798C (no)
AT (2) ATA39088A (no)
AU (1) AU618577B2 (no)
CA (1) CA1317956C (no)
CS (1) CS274578B2 (no)
DD (1) DD279021A5 (no)
DE (1) DE58907804D1 (no)
DK (1) DK170047B1 (no)
EG (1) EG20261A (no)
ES (1) ES2054887T3 (no)
FI (1) FI89491C (no)
HR (1) HRP940825A2 (no)
HU (1) HU201084B (no)
IL (1) IL89185A (no)
LT (1) LT3947B (no)
MY (1) MY103825A (no)
NO (1) NO176050C (no)
NZ (1) NZ227939A (no)
PH (1) PH26156A (no)
SI (1) SI8910358A (no)
SU (1) SU1729293A3 (no)
UA (1) UA13481A (no)
YU (1) YU35889A (no)
ZA (1) ZA891108B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0376633B1 (en) * 1988-12-28 1994-10-12 Suntory Limited Benzoxazepine derivatives
WO2005115992A1 (en) 2004-05-23 2005-12-08 Housey Pharmaceuticals, Inc. Theramutein modulators
US8431110B2 (en) 2005-05-23 2013-04-30 Hmi Medical Innovations, Llc. Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators
JP2009523408A (ja) * 2005-11-23 2009-06-25 ジェラルド・エム・ハウシー タンパク質モジュレーターを同定、合成、最適化および解析する化合物群および方法群
CN101186612B (zh) * 2006-11-15 2012-10-03 天津和美生物技术有限公司 可抑制细胞释放肿瘤坏死因子的吡咯啉衍生物及其制备和应用
US8551560B2 (en) * 2008-05-23 2013-10-08 Intermolecular, Inc. Methods for improving selectivity of electroless deposition processes

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL47877A (en) 1974-08-26 1978-10-31 Sparamedica Ag Thienothiazine carboxamide derivatives,their manufacture and pharmaceutical compositions containing them
DE2534689B2 (de) 1974-09-16 1979-03-01 Basf Ag, 6700 Ludwigshafen 23-Dihydro-3-oxo-thieno-isothiazol-1,1-dioxide
LU78009A1 (de) 1977-08-22 1979-05-23 Hoffmann La Roche Verfahren zur herstellung von thiazinderivaten
AU518216B2 (en) 1977-09-06 1981-09-17 Hafslund Nycomed Pharma Aktiengesellschaft Thienothiazine derivatives
DE2749640A1 (de) 1977-11-05 1979-05-10 Thomae Gmbh Dr K Ein thieno eckige klammer auf 3,2-d eckige klammer zu isothiazolondioxid, verfahren zu seiner herstellung und dessen verwendung
AT364852B (de) * 1977-11-05 1981-11-25 Thomae Gmbh Dr K Verfahren zur herstellung von kondensierten isothiazol-3(2h)-on-1,1-dioxiden und von deren salzen
DE2839266A1 (de) 1978-09-09 1980-03-20 Thomae Gmbh Dr K Kondensierte isothiazol-3(2h)-on-1,1- dioxide, verfahren zu deren herstellung und deren verwendung
ATE26720T1 (de) 1982-09-09 1987-05-15 Hoffmann La Roche Thieno(2,3-e)-1,2-thiazin-derivate.
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
FI862513A (fi) * 1985-07-04 1987-01-05 Chemie Linz Ag Nya tieno-1,2-tiazolderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat.
US4675403A (en) * 1985-10-16 1987-06-23 American Home Products Corporation 3-Aminoalkyl derivatives of 5,5-disubstituted hydantoins with psychotropic activity
US4732984A (en) * 1985-10-17 1988-03-22 American Home Products Corporation Piperazinoisothiazolones with psychotropic activity

Also Published As

Publication number Publication date
LT3947B (en) 1996-05-27
CA1317956C (en) 1993-05-18
LTIP1813A (en) 1995-08-25
NO890691D0 (no) 1989-02-17
UA13481A (uk) 1997-04-25
DK170047B1 (da) 1995-05-08
YU35889A (en) 1990-06-30
CS93189A2 (en) 1990-10-12
ZA891108B (en) 1989-10-25
NO890691L (no) 1989-08-21
PH26156A (en) 1992-03-18
FI89491B (fi) 1993-06-30
CN1024798C (zh) 1994-06-01
FI890690A0 (fi) 1989-02-14
FI890690A (fi) 1989-08-19
HUT50839A (en) 1990-03-28
IL89185A (en) 1992-08-18
EP0328913A3 (de) 1991-01-23
NZ227939A (en) 1991-02-26
EG20261A (en) 1998-05-31
AU2994589A (en) 1989-08-24
CS274578B2 (en) 1991-08-13
CN1038646A (zh) 1990-01-10
AU618577B2 (en) 1992-01-02
ATE106888T1 (de) 1994-06-15
SU1729293A3 (ru) 1992-04-23
ES2054887T3 (es) 1994-08-16
IL89185A0 (en) 1989-09-10
DD279021A5 (de) 1990-05-23
HU201084B (en) 1990-09-28
MY103825A (en) 1993-09-30
DK73289A (da) 1989-10-11
JPH01249779A (ja) 1989-10-05
ATA39088A (de) 1990-06-15
SI8910358A (sl) 1997-02-28
DE58907804D1 (de) 1994-07-14
EP0328913B1 (de) 1994-06-08
NO176050C (no) 1995-01-25
NO176050B (no) 1994-10-17
KR890013033A (ko) 1989-09-21
EP0328913A2 (de) 1989-08-23
FI89491C (fi) 1993-10-11
DK73289D0 (da) 1989-02-17
US4929616A (en) 1990-05-29

Similar Documents

Publication Publication Date Title
NO149888C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-substituerte-2`-hydroksyl-6,7-benzomorfaner og syreaddisjonssalter derav
DE3566545D1 (en) 2-substituted-1,3-propylidenediphosphonate derivatives, the process for their preparation and pharmaceutical compositions containing them
IE871867L (en) Solutions of oxazaphosphorins
HRP940825A2 (en) Process for the preparation of basically susbtituted 5-halothienoisothiazol-3(2h)-one-1,1-dioxides
ZA876740B (en) Derivatives of 4,5-dihydrooxazoles,a process for their preparation and their use
GR3020292T3 (en) Use of 2-iminothiazolidin-4-one derivatives as new medicaments
DE3676378D1 (de) Isoxazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutischen praeparate.
ZA88639B (en) Substituted 3-phenyl-7h-thiazolo(3,2-b)(1,2,4)triazin-7-ones,a process for the preparation thereof,medicaments containing same and the use thereof,and also some intermediates formed in the preparation of the compounds mentioned
ZA859744B (en) Unsymmetrical dihydrodithiazines,a process for their preparation and their use as fragrances and flavourings
DE3372970D1 (en) 6-alpha-methyl-prednisolone derivatives, their preparation and utilization
ES8306748A1 (es) "procedimiento para la preparacion de 2-piridil-(3')-tiazolinas".

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODBC Application rejected